U.S. Asthma Therapeutics Market New Product Classes Offer Significant Growth Opportunities

1
U.S. Asthma Therapeutics MarketNew Product
Classes Offer Significant Growth Opportunities

• The emergence of leukotriene modifiers and
  combination therapies show promise in a highly
  competitive market. Convenience is the primary
  advantage of combination therapies, as these
  pills combine two or more asthma drugs into one
  dosage, making treatment more efficient.

Pharmaceuticals Analyst Team Frost Sullivan
2
Key Features

• Detailed insights into recent developments and
  trends
• Drivers, restraints, challenges, and strategic
  recommendations
• Analytical insights into hot topics and
  emerging
• applications in the asthma therapeutics market.
• Market-sizing and competitive analysis
• Market forecasts and opportunity analyses
• Quarterly assessments
• End-user analysis

3
What We Offer

• Coverage The United States
• Proven methodology using extensive primary and
  secondary data as well as research
• Focused information and strategies that cover
  business and technology issues
• Credible data and analyses that highlight
  industry dynamics
• Precise strategies to help you create winning
  business plans

4
Who Will Benefit?

• Current Market Participants
• Find out how you compare with the competition
• Assess current and future drivers as well as
  restraints
• Determine and exploit new market share
  opportunities
• New Entrants
• Analyze the associated challenges
• Calculate timescales for strategy implementation
• Position yourself to capitalize on the unmet
  needs of the market
• Investment Community
• Analyze long-term strategies of companies
• Determine which participants will outperform the
  competition
• Assess the attractiveness of investing in the
  market

5
Key Market Participants
Alpharma, Inc./U.S. Pharmaceutical
Division AstraZeneca AstraZeneca LP Aventis
Pharmaceuticals, Inc. Bausch Lomb
Pharmaceuticals, Inc. Boehringer Ingelheim
Gmbh Copley Pharmaceuticals, Inc. Dey, Inc. Dura
Pharmaceuticals, Inc.
GlaxoSmithKline Medeva Pharmaceuticals,
Inc. Novartis Pharmaceuticals Corp. Pfizer,
Inc. Purdue Pharma LP Sanofi-Synthelabo,
Inc. Schering-Plough Corp. Teva Pharmaceutials USA
6
For More Information

• Call toll free 877 GO FROST
• (877.463.7876)
• Fax toll free 888.690.3329
• E-mail myfrost_at_frost.com
• Visit www.frost.com